HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Risperidone intoxication in a patient with a genetic predisposition as "poor [non]metabolizer"].

AbstractOBJECTIVE:
The enzyme system cytochrome P450 plays a central role in the metabolism of drugs in the human body. The enzyme CYP2D6 is important for the metabolism of psychoactive agents. Genetic changes in the CYP2D6 gene can lead to reduced or absent activity.
METHODS:
We report on a 37-year-old female patient who was given risperidone to treat an acute delusional disorder. Despite receiving a very low dose, the patient suffered from an intoxication. We inferred that an excessively raised plasma level of risperidone may result from a pharmacologically relevant disorder of metabolism.
RESULTS:
The molecular genetic investigation revealed a compound heterozygous mutation in the CYP2D6 gene and thus documented a genetic predisposition as a "poor [non]metabolizer".
CONCLUSIONS:
In intoxications with psychoactive agents, the presence of an enzyme defect in the P450 system should be considered as an additional possible cause.
AuthorsMaria Strauss, Wolfram Heinritz, Ulrich Hegerl, Andrea Kopf
JournalPsychiatrische Praxis (Psychiatr Prax) Vol. 37 Issue 4 Pg. 199-201 (May 2010) ISSN: 1439-0876 [Electronic] Germany
Vernacular TitleRisperidonintoxikation bei genetischer Disposition als "poor [non]metabolizer".
PMID20225176 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antipsychotic Agents
  • Cyclohexanols
  • Serotonin Uptake Inhibitors
  • Venlafaxine Hydrochloride
  • Cytochrome P-450 CYP2D6
  • Risperidone
Topics
  • Adult
  • Antipsychotic Agents (pharmacokinetics, therapeutic use, toxicity)
  • Chromosomes, Human, Pair 22 (genetics)
  • Cyclohexanols (pharmacokinetics, therapeutic use)
  • Cytochrome P-450 CYP2D6 (genetics)
  • DNA Mutational Analysis
  • Delusions (blood, drug therapy, genetics)
  • Dose-Response Relationship, Drug
  • Drug Monitoring
  • Drug Therapy, Combination
  • Exons (genetics)
  • Female
  • Genetic Carrier Screening
  • Humans
  • Inactivation, Metabolic (genetics)
  • Introns (genetics)
  • Metabolic Clearance Rate
  • Psychotic Disorders (blood, drug therapy, genetics)
  • Risperidone (pharmacokinetics, therapeutic use, toxicity)
  • Selective Serotonin Reuptake Inhibitors (adverse effects, therapeutic use)
  • Venlafaxine Hydrochloride

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: